Shimon Izhakian

Dr. Shimon Izhakian

Rabin Medical Center, Petah Tikva, Israel
+1
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2016 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
BVBaruch Vainshelboim
Baruch Vainshelboim
MKMordechai Reuven Reuven Kramer
Mordechai Reuven Reuven Kramer
SIShimon Izhakian
Shimon Izhakian
RLRICARDO LIMA
RICARDO LIMA
JOJose Oliveira
Jose Oliveira
Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease that manifests in hypoxemia, inactivity, and poor prognosis. This study aimed to assess the prognostic role of physical activity (PA) and exertional desaturation (ED) with mortality in IPF. At baseline, 34 IPF patients (68 (50–81) years) were interviewed using the International Physical Activity Questionnaire (IPAQ), and SpO2 was assessed pre to post 6-min walking test (∆SpO2). Patients were prospectively followed up for 40 months. Receiver operating characteristics curve analysis determined cut-off points associated with mortality, and Cox proportional hazard ratio (HR) were conducted. Thresholds for increased mortality risk in IPF patients were determined as IPAQ ≤ 417 metabolic equivalent task (METS)-min/week, p = 0.004 (HR; 9.7, CI 95% (1.3–71.9), p = 0.027), and ∆SpO2 ≥ 10%, p = 0.002, (HR; 23.3, CI 95% (1.5–365), p = 0.025). This study demonstrated a significant association of PA and ED with mortality in IPF patients. The findings emphasize the clinical importance of PA and ED assessments to aid in IPF risk stratification, prognosis prediction, and in providing early appropriate treatments, such as pulmonary rehabilitation, PA consultation, oxygen supplementation, and lung transplantation referral. These results underscore that even low levels of PA corresponding to 100–105 min/week were associated with a reduced mortality risk and better survival in IPF.

20 December 2019 in Clinical Transplantation
Verified
Journal Article
Closed access
PDF file
OWOri Wand
Ori Wand
AUAvraham Unterman
Avraham Unterman
SIShimon Izhakian
Shimon Izhakian
LFLudmila Fridel
Ludmila Fridel
MKMordechai R. Kramer
Mordechai R. Kramer

18 April 2016 in Disease Markers
Verified
Journal Article
Open access
PDF file
SIShimon Izhakian
Shimon Izhakian
WWWalter G. Wasser
Walter G. Wasser
BFBenjamin D. Fox
Benjamin D. Fox
BVBaruch Vainshelboim
Baruch Vainshelboim
MKMordechai R. Kramer
Mordechai R. Kramer
Purpose. The aim of this study was to evaluate the sensitivity of pleural C-reactive protein (CRP) biomarker levels in identifying parapneumonic effusions.Methods. A single-center, retrospective review of 244 patients diagnosed with pleural effusions was initiated among patients at the Rabin Medical Center, Petah Tikva, Israel, between January 2011 and December 2013. The patients were categorized into 4 groups according to their type of pleural effusion as follows: heart failure, malignant, post-lung transplantation, and parapneumonic effusion.Results. The pleural CRP levels significantly differentiated the four groups (p<0.001) with the following means: parapneumonic effusion,5.38±4.85 mg/dL; lung transplant,2.77±2.66 mg/dL; malignancy,1.19±1.51 mg/dL; and heart failure,0.57±0.81 mg/dL. The pleural fluid CRP cut-off value for differentiating among parapneumonic effusions and the other 3 groups was 1.38 mg/dL. The sensitivity, specificity, positive predictive value, and negative predictive value were 84.2%, 71.5%, 37%, and 95%, respectively. A backward logistic regression model selected CRP as the single predictor of parapneumonic effusion (OR = 1.59, 95% CI = 1.37–1.89).Conclusions. Pleural fluid CRP levels can be used to distinguish between parapneumonic effusions and other types of exudative effusions. CRP levels < 0.64 mg/dL are likely to indicate a pleural effusion from congestive heart failure, whereas levels ≥ 1.38 mg/dL are suggestive of an infectious etiology.

13 December 2016 in Respiration
Verified
Journal Article
Open access
AUAvraham Unterman
Avraham Unterman
OFOren Fruchter
Oren Fruchter
DRDror Rosengarten
Dror Rosengarten
SIShimon Izhakian
Shimon Izhakian
NANader Abdel-Rahman
Nader Abdel-Rahman
MKMordechai R. Kramer
Mordechai R. Kramer
Background: Lung abscesses are commonly treated with antibiotics. However, some patients fail to respond and may require percutaneous catheter drainage or surgical intervention. Bronchoscopic drainage (BD) of lung abscesses emerged as a therapeutic alternative in selected patients. Objective: To describe our experience with 15 patients who underwent BD at our center during 2006-2016. Methods: Patients underwent flexible bronchoscopy. Under fluoroscopic guidance, a pigtail catheter was introduced into the abscess cavity, its correct position being confirmed by the injection of contrast medium. The catheter remained in place for a few days and was flushed repeatedly with antibiotics. Results: Fifteen patients (9 males; median age 59 years) underwent 16 BD procedures. A pigtail catheter was successfully inserted and pus was drained from the abscess cavity in 13 procedures (81%) conducted in 12 patients, leading to rapid clinical improvement in 10 of them; resolution of fever occurred a median of 2 days (range <1-4) following pigtail insertion, and patients were discharged after 8 days (range 4-21). The pigtail catheter was extracted after a median of 4 days (range 2-6). Conclusion: BD of lung abscesses was achieved in 13 out of 16 procedures, leading to rapid improvement in the majority of patients. This work adds to the existing literature in establishing this procedure as an acceptable therapeutic alternative in selected patients who fail to respond to antibiotics, especially those with an airway obstruction or a fairly central lung abscess.

30 October 2017 in BMC Pulmonary Medicine
Verified
Journal Article
Open access
PDF file
OGOleg Gorelik
Oleg Gorelik
ITIrma Tzur
Irma Tzur
DBDana Barchel
Dana Barchel
DADorit Almoznino-Sarafian
Dorit Almoznino-Sarafian
MSMuhareb Swarka
Muhareb Swarka
SIShimon Izhakian
Shimon Izhakian
Clinical characteristics and the prognostic significance of changes in mean platelet volume (MPV) during hospitalization for community-acquired pneumonia (CAP) have not been investigated. Among 976 adults hospitalized for CAP, clinical characteristics, in-hospital outcomes (transfer to the intensive care unit, treatment with mechanical ventilation, prolonged hospital stay and death), and all-cause mortality following discharge, were compared according to ΔMPV (MPV on discharge minus MPV on admission): groups A (no rising MPV, ΔMPV < 0.6 fL) and B (rising MPV, ΔMPV ≥ 0.6 fL). Groups A and B comprised 83.8% and 16.2% of patients, respectively. Patients with a rise in MPV were more likely to be older, and to present with renal dysfunction, cerebrovascular disorder and severe pneumonia than were patients with no rise in MPV. On discharge, lower values of platelets and higher levels of neutrophils were observed in group B. Rising MPV strongly predicted a need for mechanical ventilation and in-hospital death (the respective relative risks: 2.62 and 6.79; 95% confidence intervals: 1.54–4.45 and 3.48–13.20). The respective 90-day, 3-year and total (median follow-up of 54 months) mortality rates were significantly higher in group B (29.1%, 43.0% and 50.0%) than group A (7.3%, 24.2% and 32.6%), p < 0.001 for all comparisons. A rise in MPV was a powerful predictor of all-cause mortality (relative risk 1.26 and 95% confidence interval 1.11–1.43). Rising MPV during hospitalization for CAP is associated with a more severe clinical profile than no rise in MPV. A rise in MPV strongly predicts in-hospital and long-term mortality.

1 July 2016 in Transplantation Proceedings
Verified
Journal Article
Closed access
SIShimon Izhakian
Shimon Izhakian
WWW.G. Wasser
W.G. Wasser
BFB.D. Fox
B.D. Fox
BVB. Vainshelboim
B. Vainshelboim
JRJ.E. Reznik
J.E. Reznik
MKM.R. Kramer
M.R. Kramer